ERBB2 and carcinoma of esophagus: As is known, overexpression of EGFR and HER2 has been observed in over 30% of esophageal carcinomas, and their overexpression is correlated with reduced survival, increased risk of recurrence, distant metastasis, and resistance to radiotherapy [18].